Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,153,143 papers from all fields of science
Search
Sign In
Create Free Account
ProMACE-MOPP protocol
Known as:
CTX/DOX/MTX/NM/PCB/PRED/VCR/VP-16
, ProMACE-MOPP
, ProMACE/MOPP
Expand
A chemotherapy combination consisting of cyclophosphamide, doxorubicin, etoposide, mechlorethamine, methotrexate, prednisone, procarbazine, and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Broader (7)
Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Etoposide
Mechlorethamine
Expand
Doxorubicin
Doxorubicin Hydrochloride
Mechlorethamine hydrochloride
Prednisone
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Clinical Status and Optimal Use of Rituximab for B-Cell Lymphomas
A. Molina
2017
Corpus ID: 41860491
The standard management of low-grade lymphoma remains controversial. Long-term follow-up studies of patients treated with…
Expand
2017
2017
A retrospective analysis of combination chemotherapy consisting cyclophosphamide, vincristine, prednisolone and procarbazine (C-MOPP) for pretreated aggressive non-Hodgkin lymphoma
福島 僚子
2017
Corpus ID: 80082337
Fukushima R, Kobayashi Y, Fukuhara S, Miyamoto K, Munakata W, Maruyama D, Kim SW, Watanabe T, Taniguchi H, Maeshima A, Tobinai K…
Expand
2007
2007
Linfoma de Hodkin en Chile: Experiencia de 15 años del Programa Nacional de Cáncer del Adulto
L. HernánGarcía
,
V. VivianLois
,
+11 authors
H. JanetRosas
2007
Corpus ID: 71539161
Median age was 37 years (15-84). Nodularsclerosis and mixed cellularity were equally expressed. Advanced stages (III & IV) were…
Expand
Review
2006
Review
2006
MOPPEBVCADChemotherapy with Limited and Conditioned Radiotherapy in Advanced Hodgkin ’ s Lymphoma : 10-Year Results , LateToxicity , and SecondTumors
P. Gobbi
,
C. Broglia
,
+11 authors
A. Federico
2006
Corpus ID: 17582106
Purpose: MOPPEBVCAD (mechlorethamine, vincristine, procarbazine, prednisone, epidoxirubicin, bleomycin, vinblastine, lomustine…
Expand
Review
2003
Review
2003
Expression of Epstein-Barr Virus Latent Membrane Protein-1 in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin ’ s Lymphoma : Associations with Presenting Features , Serum Interleukin 10 Levels…
Marco Herling
,
G. Rassidakis
,
+14 authors
A. Sarris
2003
Corpus ID: 30307919
Purpose: EBV-latent membrane protein-1 (LMP-1) is often expressed in Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin…
Expand
Review
2002
Review
2002
Cyclin D 3 Is a Predictive and Prognostic Factor in Diffuse Large B-cell Lymphoma 1
M. Filipits
,
U. Jaeger
,
+5 authors
R. Pirker
2002
Corpus ID: 44212985
Cyclin D3 is an important regulator for transition from G1 to the S phase of the cell cycle. Cyclin D3 expression is associated…
Expand
2001
2001
[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
M. Shtalrid
,
M. Haran
,
A. Klepfish
,
Y. Lurie
,
S. Malnick
Harefuah
2001
Corpus ID: 36939480
Chemotherapy administration to patients with lymphoproliferative diseases that are carriers of hepatitis B can be complicated by…
Expand
1998
1998
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
G. Marotta
,
C. Bigazzi
,
M. Bocchia
,
F. Forconi
,
F. Lauria
Haematologica
1998
Corpus ID: 32719106
Long-lasting results achieved in 54 patients with aggressive non-Hodgkin lymphoma treated with Pro-MACE-CytaBOM regimen were…
Expand
1980
1980
[Chemotherapy of MOPP and C-MOPP resistant cases of malignant lymphoma. (A preliminary report) (author's transl)].
K. Kolarić
,
R. Tomek
,
A. Roth
Liječnički vjesnik
1980
Corpus ID: 11441745
1979
1979
A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non‐Hodgkin's lymphoma
H. Brereton
,
R. Young
,
+5 authors
Ralph E. Johnson
Cancer
1979
Corpus ID: 45930512
Thirty‐nine untreated patients with either lymphocytic or nodular mixed/nodular histiocytic non‐Hodgkin's lymphoma, stage II‐IV…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE